{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:57:10Z","timestamp":1794013030980,"version":"4.8.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A2B4012840"],"award-info":[{"award-number":["2016R1A2B4012840"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A4A1025985"],"award-info":[{"award-number":["2018R1A4A1025985"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A2B4012840"],"award-info":[{"award-number":["2016R1A2B4012840"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A4A1025985"],"award-info":[{"award-number":["2018R1A4A1025985"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1A2B4012840"],"award-info":[{"award-number":["2016R1A2B4012840"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A4A1025985"],"award-info":[{"award-number":["2018R1A4A1025985"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1038\/s12276-019-0230-6","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:24:24Z","timestamp":1561015464000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["The cancer driver genes IDH1\/2, JARID1C\/ KDM5C, and UTX\/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism"],"prefix":"10.1038","volume":"51","author":[{"given":"Soojeong","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"230_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/nar\/gkw848","volume":"45","author":"R Wu","year":"2017","unstructured":"Wu, R., Wang, Z., Zhang, H., Gan, H. & Zhang, Z. H3K9me3 demethylase Kdm4d facilitates the formation of pre-initiative complex and regulates DNA replication. Nucleic Acids Res. 45, 169\u2013180 (2017).","journal-title":"Nucleic Acids Res."},{"key":"230_CR2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0006-291X(78)91010-0","volume":"83","author":"R Myllyla","year":"1978","unstructured":"Myllyla, R., Kuutti-Savolainen, E. R. & Kivirikko, K. I. The role of ascorbate in the prolyl hydroxylase reaction. Biochem. Biophys. Res. Commun. 83, 441\u2013448 (1978).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"230_CR3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi, Y. et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941\u2013953 (2004).","journal-title":"Cell"},{"key":"230_CR4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/MCB.00444-09","volume":"30","author":"AJ Krieg","year":"2010","unstructured":"Krieg, A. J. et al. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol. 30, 344\u2013353 (2010).","journal-title":"Mol. Cell. Biol."},{"key":"230_CR5","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/carcin\/bgt256","volume":"34","author":"HY Lee","year":"2013","unstructured":"Lee, H. Y., Yang, E. G. & Park, H. Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases. Carcinogenesis 34, 2706\u20132715 (2013).","journal-title":"Carcinogenesis"},{"key":"230_CR6","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.jmb.2018.06.048","volume":"430","author":"T Laukka","year":"2018","unstructured":"Laukka, T., Myllykoski, M., Looper, R. E. & Koivunen, P. Cancer-associated 2-oxoglutarate analogues modify histone methylation by inhibiting histone lysine demethylases. J. Mol. Biol. 430, 3081\u20133092 (2018).","journal-title":"J. Mol. Biol."},{"key":"230_CR7","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang, L. et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739\u2013744 (2009).","journal-title":"Nature"},{"key":"230_CR8","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1182\/blood-2013-03-493197","volume":"121","author":"CD DiNardo","year":"2013","unstructured":"DiNardo, C. D. et al. Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood 121, 4917\u20134924 (2013).","journal-title":"Blood"},{"key":"230_CR9","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807\u20131812 (2008).","journal-title":"Science"},{"key":"230_CR10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","volume":"361","author":"ER Mardis","year":"2009","unstructured":"Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058\u20131066 (2009).","journal-title":"N. Engl. J. Med."},{"key":"230_CR11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765\u2013773 (2009).","journal-title":"N. Engl. J. Med."},{"key":"230_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward, P. S. et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225\u2013234 (2010).","journal-title":"Cancer Cell"},{"key":"230_CR13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","volume":"17","author":"DR Borger","year":"2012","unstructured":"Borger, D. R. et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17, 72\u201379 (2012).","journal-title":"Oncologist"},{"key":"230_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/neuonc\/nov136","volume":"18","author":"MS Waitkus","year":"2016","unstructured":"Waitkus, M. S., Diplas, B. H. & Yan, H. Isocitrate dehydrogenase mutations in gliomas. Neuro. Oncol. 18, 16\u201326 (2016).","journal-title":"Neuro. Oncol."},{"key":"230_CR15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/leu.2016.275","volume":"31","author":"BC Medeiros","year":"2017","unstructured":"Medeiros, B. C. et al. Isocitrate dehydrogenase mutations in myeloid malignancies. Leukemia 31, 272\u2013281 (2017).","journal-title":"Leukemia"},{"key":"230_CR16","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang, H., Ye, D., Guan, K. L. & Xiong, Y. IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin. Cancer Res. 18, 5562\u20135571 (2012).","journal-title":"Clin. Cancer Res."},{"key":"230_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.24379","volume":"125","author":"MR Kang","year":"2009","unstructured":"Kang, M. R. et al. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int. J. Cancer 125, 353\u2013355 (2009).","journal-title":"Int. J. Cancer"},{"key":"230_CR18","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1231677","volume":"339","author":"JA Losman","year":"2013","unstructured":"Losman, J. A. et al. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339, 1621\u20131625 (2013).","journal-title":"Science"},{"key":"230_CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-biochem-061516-044732","volume":"86","author":"L Dang","year":"2017","unstructured":"Dang, L. & Su, S. M. Isocitrate dehydrogenase mutation and (R)-2-hydroxyglutarate: from basic discovery to therapeutics development. Annu. Rev. Biochem. 86, 305\u2013331 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"230_CR20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.tcb.2017.06.002","volume":"27","author":"LM Gagn\u00e9","year":"2017","unstructured":"Gagn\u00e9, L. M., Boulay, K., Topisirovic, I., Huot, M. E. & Mallette, F. A. Oncogenic activities of IDH1\/2 mutations: from epigenetics to cellular signaling. Trends Cell Biol. 27, 738\u2013752 (2017).","journal-title":"Trends Cell Biol."},{"key":"230_CR21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/cb500683c","volume":"10","author":"J Fan","year":"2015","unstructured":"Fan, J. et al. Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate. Acs Chem. Biol. 10, 510\u2013516 (2015).","journal-title":"Acs Chem. Biol."},{"key":"230_CR22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346\u2013350 (2011).","journal-title":"Nature"},{"key":"230_CR23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI71180","volume":"124","author":"A Terunuma","year":"2014","unstructured":"Terunuma, A. et al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest. 124, 398\u2013412 (2014).","journal-title":"J. Clin. Invest."},{"key":"230_CR24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20092506","volume":"207","author":"S Gross","year":"2010","unstructured":"Gross, S. et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J. Exp. Med. 207, 339\u2013344 (2010).","journal-title":"J. Exp. Med."},{"key":"230_CR25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/glia.21130","volume":"59","author":"M Weller","year":"2011","unstructured":"Weller, M., Wick, W. & von Deimling, A. Isocitrate dehydrogenase mutations: a challenge to traditional views on the genesis and malignant progression of gliomas. Glia 59, 1200\u20131204 (2011).","journal-title":"Glia"},{"key":"230_CR26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","volume":"12","author":"R Chowdhury","year":"2011","unstructured":"Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12, 463\u2013469 (2011).","journal-title":"EMBO Rep."},{"key":"230_CR27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17\u201330 (2011).","journal-title":"Cancer Cell"},{"key":"230_CR28","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","volume":"22","author":"AM Intlekofer","year":"2015","unstructured":"Intlekofer, A. M. et al. Hypoxia induces production of L-2-hydroxyglutarate. Cell. Metab. 22, 304\u2013311 (2015).","journal-title":"Cell. Metab."},{"key":"230_CR29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cmet.2015.06.021","volume":"22","author":"WM Oldham","year":"2015","unstructured":"Oldham, W. M., Clish, C. B., Yang, Y. & Loscalzo, J. Hypoxia-mediated increases in L-2-hydroxyglutarate coordinate the metabolic response to reductive stress. Cell Metab. 22, 291\u2013303 (2015).","journal-title":"Cell Metab."},{"key":"230_CR30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nchembio.2307","volume":"13","author":"AM Intlekofer","year":"2017","unstructured":"Intlekofer, A. M. et al. L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH. Nat. Chem. Biol. 13, 494\u2013500 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"230_CR31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nchembio.1141","volume":"9","author":"CL Linster","year":"2013","unstructured":"Linster, C. L., Van Schaftingen, E. & Hanson, A. D. Metabolite damage and its repair or pre-emption. Nat. Chem. Biol. 9, 72\u201380 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"230_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biochi.2005.06.005","volume":"88","author":"R Rzem","year":"2006","unstructured":"Rzem, R., Van Schaftingen, E. & Veiga-da-Cunha, M. The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase. Biochimie 88, 113\u2013116 (2006).","journal-title":"Biochimie"},{"key":"230_CR33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.mito.2014.02.009","volume":"19 Pt B","author":"MK Engqvist","year":"2014","unstructured":"Engqvist, M. K., Esser, C., Maier, A., Lercher, M. J. & Maurino, V. G. Mitochondrial 2-hydroxyglutarate metabolism. Mitochondrion 19 Pt B, 275\u2013281 (2014).","journal-title":"Mitochondrion"},{"key":"230_CR34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ncb3529","volume":"19","author":"E Anso","year":"2017","unstructured":"Anso, E. et al. The mitochondrial respiratory chain is essential for haematopoietic stem cell function. Nat. Cell Biol. 19, 614\u2013625 (2017).","journal-title":"Nat. Cell Biol."},{"key":"230_CR35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.1192632","volume":"330","author":"M Kranendijk","year":"2010","unstructured":"Kranendijk, M. et al. IDH2 mutations in patients with D-2-hydroxyglutaric aciduria. Science 330, 336 (2010).","journal-title":"Science"},{"key":"230_CR36","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/01.WNL.0000125335.21381.87","volume":"62","author":"I Moroni","year":"2004","unstructured":"Moroni, I. et al. L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology 62, 1882\u20131884 (2004).","journal-title":"Neurology"},{"key":"230_CR37","doi-asserted-by":"publisher","unstructured":"Ma, S. et al. L2hgdh deficiency accumulates l-2-hydroxyglutarate with progressive leukoencephalopathy and neurodegeneration. Mol Cell Biol 37, https:\/\/doi.org\/10.1128\/MCB.00492-16 (2017).","DOI":"10.1128\/MCB.00492-16"},{"key":"230_CR38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732\u2013744 (2011).","journal-title":"Cell"},{"key":"230_CR39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","volume":"356","author":"N Wong","year":"2015","unstructured":"Wong, N., Ojo, D., Yan, J. & Tang, D. PKM2 contributes to cancer metabolism. Cancer Lett. 356, 184\u2013191 (2015).","journal-title":"Cancer Lett."},{"key":"230_CR40","doi-asserted-by":"crossref","first-page":"16825","DOI":"10.1074\/jbc.R117.799973","volume":"292","author":"H Xie","year":"2017","unstructured":"Xie, H. & Simon, M. C. Oxygen availability and metabolic reprogramming in cancer. J. Biol. Chem. 292, 16825\u201316832 (2017).","journal-title":"J. Biol. Chem."},{"key":"230_CR41","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"230_CR42","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1016\/S0021-9258(20)82128-0","volume":"259","author":"RW Moreadith","year":"1984","unstructured":"Moreadith, R. W. & Lehninger, A. L. The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+ -dependent malic enzyme. J. Biol. Chem. 259, 6215\u20136221 (1984).","journal-title":"J. Biol. Chem."},{"key":"230_CR43","first-page":"350","volume":"9","author":"E R","year":"1949","unstructured":"R, E. et al. Amino acids in epidermal carcinogenesis in mice. Cancer Res. 9, 350\u2013353 (1949).","journal-title":"Cancer Res."},{"key":"230_CR44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/0008-5472.CAN-14-2211","volume":"75","author":"JJ Kamphorst","year":"2015","unstructured":"Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75, 544\u2013553 (2015).","journal-title":"Cancer Res."},{"key":"230_CR45","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/ncb3410","volume":"18","author":"M Pan","year":"2016","unstructured":"Pan, M. et al. Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nat. Cell Biol. 18, 1090\u20131101 (2016).","journal-title":"Nat. Cell Biol."},{"key":"230_CR46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393\u2013410 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"230_CR47","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371\u2013385 e318 (2018).","journal-title":"Cell"},{"key":"230_CR48","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1074\/jbc.M115.698449","volume":"291","author":"JR Horton","year":"2016","unstructured":"Horton, J. R. et al. Characterization of a linked Jumonji domain of the KDM5\/JARID1 family of histone H3 lysine 4 demethylases. J. Biol. Chem. 291, 2631\u20132646 (2016).","journal-title":"J. Biol. Chem."},{"key":"230_CR49","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1128\/MCB.00274-07","volume":"27","author":"AG Scibetta","year":"2007","unstructured":"Scibetta, A. G. et al. Functional analysis of the transcription repressor PLU-1\/JARID1B. Mol. Cell. Biol. 27, 7220\u20137235 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"230_CR50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.celrep.2013.12.021","volume":"6","author":"BJ Klein","year":"2014","unstructured":"Klein, B. J. et al. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers. Cell Rep. 6, 325\u2013335 (2014).","journal-title":"Cell Rep."},{"key":"230_CR51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s13238-014-0078-4","volume":"5","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. The PHD1 finger of KDM5B recognizes unmodified H3K4 during the demethylation of histone H3K4me2\/3 by KDM5B. Protein Cell 5, 837\u2013850 (2014).","journal-title":"Protein Cell"},{"key":"230_CR52","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-11-1523","volume":"71","author":"Q Li","year":"2011","unstructured":"Li, Q. et al. Binding of the JmjC demethylase JARID1B to LSD1\/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 71, 6899\u20136908 (2011).","journal-title":"Cancer Res."},{"key":"230_CR53","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/MCB.06373-11","volume":"32","author":"PP Wong","year":"2012","unstructured":"Wong, P. P. et al. Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitorp21(cip) (CDKN1A). Mol. Cell. Biol. 32, 1633\u20131644 (2012).","journal-title":"Mol. Cell. Biol."},{"key":"230_CR54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/427563","volume":"76","author":"LR Jensen","year":"2005","unstructured":"Jensen, L. R. et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76, 227\u2013236 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"230_CR55","doi-asserted-by":"crossref","first-page":"e0140257","DOI":"10.1371\/journal.pone.0140257","volume":"10","author":"CJ Ricketts","year":"2015","unstructured":"Ricketts, C. J. & Linehan, W. M. Gender specific mutation incidence and survival associations in clear cell renal cell carcinoma (CCRCC). PLoS ONE 10, e0140257 (2015).","journal-title":"PLoS ONE"},{"key":"230_CR56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","volume":"49","author":"A Dunford","year":"2017","unstructured":"Dunford, A. et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat. Genet. 49, 10\u201316 (2017).","journal-title":"Nat. Genet."},{"key":"230_CR57","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1136\/jmg.2008.058990","volume":"45","author":"FE Abidi","year":"2008","unstructured":"Abidi, F. E. et al. Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia. J. Med. Genet. 45, 787\u2013793 (2008).","journal-title":"J. Med. Genet."},{"key":"230_CR58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnmol.2018.00104","volume":"11","author":"CN Vallianatos","year":"2018","unstructured":"Vallianatos, C. N. et al. Altered gene-regulatory function of KDM5C by a novel mutation associated with autism and intellectual disability. Front. Mol. Neurosci. 11, 104 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"230_CR59","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","volume":"463","author":"GL Dalgliesh","year":"2010","unstructured":"Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360\u2013363 (2010).","journal-title":"Nature"},{"key":"230_CR60","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/onc.2011.266","volume":"31","author":"X Niu","year":"2012","unstructured":"Niu, X. et al. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 31, 776\u2013786 (2012).","journal-title":"Oncogene"},{"key":"230_CR61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539\u2013542 (2011).","journal-title":"Nature"},{"key":"230_CR62","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1073\/pnas.0914818107","volume":"107","author":"JA Smith","year":"2010","unstructured":"Smith, J. A. et al. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. USA 107, 3752\u20133757 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"230_CR63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1101\/gr.123109.111","volume":"22","author":"L Wang","year":"2012","unstructured":"Wang, L. et al. Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Genome Res. 22, 208\u2013219 (2012).","journal-title":"Genome Res."},{"key":"230_CR64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.celrep.2013.02.030","volume":"3","author":"NS Outchkourov","year":"2013","unstructured":"Outchkourov, N. S. et al. Balancing of histone H3K4 methylation states by the Kdm5c\/SMCX histone demethylase modulates promoter and enhancer function. Cell Rep. 3, 1071\u20131079 (2013).","journal-title":"Cell Rep."},{"key":"230_CR65","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1172\/JCI81040","volume":"125","author":"B Rondinelli","year":"2015","unstructured":"Rondinelli, B. et al. Histone demethylase JARID1C inactivation triggers genomic instability in sporadic renal cancer. J. Clin. Invest. 125, 4625\u20134637 (2015).","journal-title":"J. Clin. Invest."},{"key":"230_CR66","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1093\/nar\/gkv090","volume":"43","author":"B Rondinelli","year":"2015","unstructured":"Rondinelli, B. et al. H3K4me3 demethylation by the histone demethylase KDM5C\/JARID1C promotes DNA replication origin firing. Nucleic Acids Res. 43, 2560\u20132574 (2015).","journal-title":"Nucleic Acids Res."},{"key":"230_CR67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/352251a0","volume":"352","author":"D Defeo-Jones","year":"1991","unstructured":"Defeo-Jones, D. et al. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352, 251\u2013254 (1991).","journal-title":"Nature"},{"key":"230_CR68","doi-asserted-by":"crossref","first-page":"15633","DOI":"10.1074\/jbc.274.22.15633","volume":"274","author":"PJ Lu","year":"1999","unstructured":"Lu, P. J. et al. A novel gene (PLU-1) containing highly conserved putative DNA\/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274, 15633\u201315645 (1999).","journal-title":"J. Biol. Chem."},{"key":"230_CR69","doi-asserted-by":"crossref","first-page":"8971","DOI":"10.1073\/pnas.1119836109","volume":"109","author":"A Chicas","year":"2012","unstructured":"Chicas, A. et al. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc. Natl. Acad. Sci. USA 109, 8971\u20138976 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"230_CR70","doi-asserted-by":"crossref","first-page":"e25235","DOI":"10.1371\/journal.pone.0025235","volume":"6","author":"JH Nijwening","year":"2011","unstructured":"Nijwening, J. H., Geutjes, E. J., Bernards, R. & Beijersbergen, R. L. The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS ONE 6, e25235 (2011).","journal-title":"PLoS ONE"},{"key":"230_CR71","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccell.2015.06.003","volume":"28","author":"SH Wong","year":"2015","unstructured":"Wong, S. H. et al. The H3K4-methyl epigenome regulates leukemia stem cell oncogenic potential. Cancer Cell. 28, 198\u2013209 (2015).","journal-title":"Cancer Cell."},{"key":"230_CR72","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1126\/science.7667640","volume":"269","author":"W Wang","year":"1995","unstructured":"Wang, W. et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269, 1588\u20131590 (1995).","journal-title":"Science"},{"key":"230_CR73","doi-asserted-by":"crossref","DOI":"10.1038\/srep44876","volume":"7","author":"M Arseneault","year":"2017","unstructured":"Arseneault, M. et al. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. Sci. Rep. 7, 44876 (2017).","journal-title":"Sci. Rep."},{"key":"230_CR74","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-15-0906","volume":"76","author":"N Li","year":"2016","unstructured":"Li, N. et al. JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis. Cancer Res. 76, 831\u2013843 (2016).","journal-title":"Cancer Res."},{"key":"230_CR75","first-page":"247","volume":"4","author":"J Hou","year":"2012","unstructured":"Hou, J. et al. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Am. J. Transl. Res. 4, 247\u2013256 (2012).","journal-title":"Am. J. Transl. Res."},{"key":"230_CR76","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/1541-7786.MCR-13-0396","volume":"12","author":"H Li","year":"2014","unstructured":"Li, H. et al. Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection. Mol. Cancer Res. 12, 571\u2013582 (2014).","journal-title":"Mol. Cancer Res."},{"key":"230_CR77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature08036","volume":"459","author":"GG Wang","year":"2009","unstructured":"Wang, G. G. et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 459, 847\u2013851 (2009).","journal-title":"Nature"},{"key":"230_CR78","doi-asserted-by":"crossref","first-page":"13379","DOI":"10.1073\/pnas.1110104108","volume":"108","author":"W Lin","year":"2011","unstructured":"Lin, W. et al. Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc. Natl. Acad. Sci. USA 108, 13379\u201313386 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"230_CR79","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1158\/0008-5472.CAN-12-3165","volume":"73","author":"YC Teng","year":"2013","unstructured":"Teng, Y. C. et al. Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis. Cancer Res. 73, 4711\u20134721 (2013).","journal-title":"Cancer Res."},{"key":"230_CR80","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/modpathol.3800413","volume":"18","author":"A Roesch","year":"2005","unstructured":"Roesch, A. et al. Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod. Pathol. 18, 1249\u20131257 (2005).","journal-title":"Mod. Pathol."},{"key":"230_CR81","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch, A. et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583\u2013594 (2010).","journal-title":"Cell"},{"key":"230_CR82","doi-asserted-by":"crossref","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"DA Scott","year":"2011","unstructured":"Scott, D. A. et al. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 286, 42626\u201342634 (2011).","journal-title":"J. Biol. Chem."},{"key":"230_CR83","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch, A. et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell 23, 811\u2013825 (2013).","journal-title":"Cancer Cell"},{"key":"230_CR84","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1158\/0008-5472.CAN-15-3377","volume":"76","author":"ND Facompre","year":"2016","unstructured":"Facompre, N. D. et al. JARID1B enables transit between distinct states of the stem-like cell population in oral cancers. Cancer Res. 76, 5538\u20135549 (2016).","journal-title":"Cancer Res."},{"key":"230_CR85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010).","journal-title":"Cell"},{"key":"230_CR86","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature06192","volume":"449","author":"F Lan","year":"2007","unstructured":"Lan, F. et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449, 689\u2013694 (2007).","journal-title":"Nature"},{"key":"230_CR87","doi-asserted-by":"crossref","first-page":"e1002964","DOI":"10.1371\/journal.pgen.1002964","volume":"8","author":"KB Shpargel","year":"2012","unstructured":"Shpargel, K. B., Sengoku, T., Yokoyama, S. & Magnuson, T. UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. PLoS Genet. 8, e1002964 (2012).","journal-title":"PLoS Genet."},{"key":"230_CR88","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1101\/gr.140988.112","volume":"22","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res. 22, 2315\u20132327 (2012).","journal-title":"Genome Res."},{"key":"230_CR89","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2015.02.008","volume":"208","author":"L Liao","year":"2015","unstructured":"Liao, L., Testa, J. R. & Yang, H. The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer. Cancer Genet 208, 206\u2013214 (2015).","journal-title":"Cancer Genet"},{"key":"230_CR90","volume":"9","author":"X Li","year":"2018","unstructured":"Li, X. et al. UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma. Nat. Commun. 9, 2720 (2018).","journal-title":"Nat. Commun."},{"key":"230_CR91","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research, N.","year":"2014","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315\u2013322 (2014).","journal-title":"Nature"},{"key":"230_CR92","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","volume":"374","author":"Cancer Genome Atlas Research, N.","year":"2016","unstructured":"Cancer Genome Atlas Research, N. et al. . Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374, 135\u2013145 (2016).","journal-title":"N. Engl. J. Med."},{"key":"230_CR93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333\u2013339 (2013).","journal-title":"Nature"},{"key":"230_CR94","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.celrep.2017.09.078","volume":"21","author":"T Ezponda","year":"2017","unstructured":"Ezponda, T. et al. UTX\/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition. Cell Rep. 21, 628\u2013640 (2017).","journal-title":"Cell Rep."},{"key":"230_CR95","doi-asserted-by":"crossref","first-page":"eaai8312","DOI":"10.1126\/scitranslmed.aai8312","volume":"9","author":"LD Ler","year":"2017","unstructured":"Ler, L. D. et al. Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2. Sci. Transl. Med. 9, eaai8312 (2017).","journal-title":"Sci. Transl. Med."},{"key":"230_CR96","doi-asserted-by":"crossref","first-page":"E3978","DOI":"10.1073\/pnas.1716589115","volume":"115","author":"Q Wu","year":"2018","unstructured":"Wu, Q. et al. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis. Proc. Natl. Acad. Sci. USA 115, E3978\u2013E3986 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"230_CR97","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41375-018-0011-6","volume":"32","author":"L Zheng","year":"2018","unstructured":"Zheng, L. et al. Utx loss causes myeloid transformation. Leukemia 32, 1458\u20131465 (2018).","journal-title":"Leukemia"},{"key":"230_CR98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","volume":"125","author":"J Van der Meulen","year":"2015","unstructured":"Van der Meulen, J. et al. The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood 125, 13\u201321 (2015).","journal-title":"Blood"},{"key":"230_CR99","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.exphem.2015.05.001","volume":"43","author":"B Xu","year":"2015","unstructured":"Xu, B., Konze, K. D., Jin, J. & Wang, G. G. Targeting EZH2 and PRC2 dependence as novel anticancer therapy. Exp. Hematol. 43, 698\u2013712 (2015).","journal-title":"Exp. Hematol."},{"key":"230_CR100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yexcr.2017.08.024","volume":"359","author":"N Yan","year":"2017","unstructured":"Yan, N. et al. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells. Exp. Cell Res. 359, 405\u2013414 (2017).","journal-title":"Exp. Cell Res."},{"key":"230_CR101","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41591-018-0034-6","volume":"24","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nat. Med. 24, 758\u2013769 (2018).","journal-title":"Nat. Med."},{"key":"230_CR102","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1101\/gad.308536.117","volume":"31","author":"M Saxena","year":"2017","unstructured":"Saxena, M. et al. Transcription factor-dependent \u2018anti-repressive\u2019 mammalian enhancers exclude H3K27me3 from extended genomic domains. Genes Dev. 31, 2391\u20132404 (2017).","journal-title":"Genes Dev."},{"key":"230_CR103","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ccell.2018.02.003","volume":"33","author":"J Andricovich","year":"2018","unstructured":"Andricovich, J. et al. Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors. Cancer Cell. 33, 512\u2013526 e518 (2018).","journal-title":"Cancer Cell."},{"key":"230_CR104","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.molcel.2017.06.028","volume":"67","author":"SP Wang","year":"2017","unstructured":"Wang, S. P. et al. A UTX-MLL4-p300 transcriptional regulatory network coordinately shapes active enhancer landscapes for eliciting transcription. Mol. Cell 67, 308\u2013321 e306 (2017).","journal-title":"Mol. Cell"},{"key":"230_CR105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41588-018-0114-z","volume":"50","author":"M Gozdecka","year":"2018","unstructured":"Gozdecka, M. et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat. Genet. 50, 883\u2013894 (2018).","journal-title":"Nat. Genet."},{"key":"230_CR106","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1101\/gad.510809","volume":"23","author":"K Agger","year":"2009","unstructured":"Agger, K. et al. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 23, 1171\u20131176 (2009).","journal-title":"Genes Dev."},{"key":"230_CR107","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1158\/0008-5472.CAN-10-4379","volume":"71","author":"F Aguilo","year":"2011","unstructured":"Aguilo, F., Zhou, M. M. & Walsh, M. J. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 71, 5365\u20135369 (2011).","journal-title":"Cancer Res."},{"key":"230_CR108","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrc1954","volume":"6","author":"CJ Sherr","year":"2006","unstructured":"Sherr, C. J. Divorcing ARF andp53: an unsettled case. Nat. Rev. Cancer 6, 663\u2013673 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"230_CR109","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/cdd.2015.6","volume":"22","author":"L Zhao","year":"2015","unstructured":"Zhao, L. et al. JMJD3 promotes SAHF formation in senescent WI38 cells by triggering an interplay between demethylation and phosphorylation of RB protein. Cell Death Differ. 22, 1630\u20131640 (2015).","journal-title":"Cell Death Differ."},{"key":"230_CR110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/nar\/gkt866","volume":"42","author":"KC Akdemir","year":"2014","unstructured":"Akdemir, K. C. et al. Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells. Nucleic Acids Res. 42, 205\u2013223 (2014).","journal-title":"Nucleic Acids Res."},{"key":"230_CR111","doi-asserted-by":"crossref","first-page":"e96545","DOI":"10.1371\/journal.pone.0096545","volume":"9","author":"K Williams","year":"2014","unstructured":"Williams, K. et al. The histone lysine demethylase JMJD3\/KDM6B is recruited to p53 bound promoters and enhancer elements in a p53 dependent manner. PLoS ONE 9, e96545 (2014).","journal-title":"PLoS ONE"},{"key":"230_CR112","doi-asserted-by":"crossref","first-page":"e51407","DOI":"10.1371\/journal.pone.0051407","volume":"7","author":"CI Ene","year":"2012","unstructured":"Ene, C. I. et al. Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization. PLoS ONE 7, e51407 (2012).","journal-title":"PLoS ONE"},{"key":"230_CR113","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1093\/hmg\/ddr399","volume":"20","author":"F Pereira","year":"2011","unstructured":"Pereira, F. et al. KDM6B\/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum. Mol. Genet. 20, 4655\u20134665 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"230_CR114","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/onc.2010.579","volume":"30","author":"JA Anderton","year":"2011","unstructured":"Anderton, J. A. et al. The H3K27me3 demethylase, KDM6B, is induced by Epstein\u2212Barr virus and over-expressed in Hodgkin\u2019s Lymphoma. Oncogene 30, 2037\u20132043 (2011).","journal-title":"Oncogene"},{"key":"230_CR115","doi-asserted-by":"crossref","first-page":"44508","DOI":"10.1074\/jbc.M112.424903","volume":"287","author":"S Ramadoss","year":"2012","unstructured":"Ramadoss, S., Chen, X. & Wang, C. Y. Histone demethylase KDM6B promotes epithelial-mesenchymal transition. J. Biol. Chem. 287, 44508\u201344517 (2012).","journal-title":"J. Biol. Chem."},{"key":"230_CR116","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-470","volume":"12","author":"Y Shen","year":"2012","unstructured":"Shen, Y. et al. Expression and significance of histone H3K27 demethylases in renal cell carcinoma. Bmc Cancer 12, 470 (2012).","journal-title":"Bmc Cancer"},{"key":"230_CR117","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/leu.2013.91","volume":"27","author":"Y Wei","year":"2013","unstructured":"Wei, Y. et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia 27, 2177\u20132186 (2013).","journal-title":"Leukemia"},{"key":"230_CR118","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1158\/1541-7786.MCR-13-0268","volume":"13","author":"PM Perrigue","year":"2015","unstructured":"Perrigue, P. M. et al. The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines. Mol. Cancer Res. 13, 636\u2013650 (2015).","journal-title":"Mol. Cancer Res."},{"key":"230_CR119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/0008-5472.CAN-15-0536","volume":"76","author":"WY Park","year":"2016","unstructured":"Park, W. Y., Hong, B. J., Lee, J., Choi, C. & Kim, M. Y. H3K27 Demethylase JMJD3 employs the NF-kappaB and BMP signaling pathways to modulate the tumor microenvironment and promote melanoma progression and metastasis. Cancer Res. 76, 161\u2013170 (2016).","journal-title":"Cancer Res."},{"key":"230_CR120","first-page":"6334","volume":"8","author":"Q Li","year":"2015","unstructured":"Li, Q. et al. KDM6B induces epithelial\u2212mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Int. J. Clin. Exp. Pathol. 8, 6334\u20136344 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"230_CR121","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","volume":"42","author":"T Ernst","year":"2010","unstructured":"Ernst, T. et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42, 722\u2013726 (2010).","journal-title":"Nat. Genet."},{"key":"230_CR122","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1101\/gad.191163.112","volume":"26","author":"H Hock","year":"2012","unstructured":"Hock, H. A complex Polycomb issue: the two faces of EZH2 in cancer. Genes Dev. 26, 751\u2013755 (2012).","journal-title":"Genes Dev."},{"key":"230_CR123","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta, J. C. et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006\u20131018 (2008).","journal-title":"Cell"},{"key":"230_CR124","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe, J. P. et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853\u20132868 (2008).","journal-title":"PLoS Biol."},{"key":"230_CR125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2008.03.039","volume":"133","author":"T Kuilman","year":"2008","unstructured":"Kuilman, T. et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019\u20131031 (2008).","journal-title":"Cell"},{"key":"230_CR126","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2007.08.019","volume":"130","author":"F De Santa","year":"2007","unstructured":"De Santa, F. et al. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083\u20131094 (2007).","journal-title":"Cell"},{"key":"230_CR127","doi-asserted-by":"crossref","first-page":"e9913","DOI":"10.1371\/journal.pone.0009913","volume":"5","author":"ND Das","year":"2010","unstructured":"Das, N. D., Jung, K. H. & Chai, Y. G. The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells. PLoS ONE 5, e9913 (2010).","journal-title":"PLoS ONE"},{"key":"230_CR128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00109-013-1090-5","volume":"92","author":"P Przanowski","year":"2014","unstructured":"Przanowski, P. et al. The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J. Mol. Med. (Berl.) 92, 239\u2013254 (2014).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"230_CR129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jid.2015.11.029","volume":"136","author":"J Na","year":"2016","unstructured":"Na, J. et al. Histone H3K27 demethylase JMJD3 in cooperation with NF-kappaB regulates keratinocyte wound healing. J. Invest. Dermatol. 136, 847\u2013858 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"230_CR130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.sbi.2016.05.013","volume":"41","author":"S Markolovic","year":"2016","unstructured":"Markolovic, S. et al. Structure\u2212function relationships of human JmjC oxygenases-demethylases versus hydroxylases. Curr. Opin. Struct. Biol. 41, 62\u201372 (2016).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"230_CR131","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1021\/bi3012466","volume":"51","author":"B Cascella","year":"2012","unstructured":"Cascella, B. & Mirica, L. M. Kinetic analysis of iron-dependent histone demethylases: alpha-ketoglutarate substrate inhibition and potential relevance to the regulation of histone demethylation in cancer cells. Biochemistry 51, 8699\u20138701 (2012).","journal-title":"Biochemistry"},{"key":"230_CR132","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12700","volume":"7","author":"M Carbonneau","year":"2016","unstructured":"Carbonneau, M. et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat. Commun. 7, 12700 (2016).","journal-title":"Nat. Commun."},{"key":"230_CR133","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","volume":"483","author":"C Lu","year":"2012","unstructured":"Lu, C. et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474\u2013478 (2012).","journal-title":"Nature"},{"key":"230_CR134","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2011.12.036","volume":"416","author":"AK Upadhyay","year":"2012","unstructured":"Upadhyay, A. K. et al. An analog of BIX-01294 selectively inhibits a family of histone H3 lysine 9 Jumonji demethylases. J. Mol. Biol. 416, 319\u2013327 (2012).","journal-title":"J. Mol. Biol."},{"key":"230_CR135","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M114.555052","volume":"289","author":"LJ Walport","year":"2014","unstructured":"Walport, L. J. et al. Human UTY(KDM6C) is a male-specific N-methyl lysyl demethylase. J. Biol. Chem. 289, 18302\u201318313 (2014).","journal-title":"J. Biol. Chem."},{"key":"230_CR136","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1074\/jbc.M115.688762","volume":"291","author":"T Laukka","year":"2016","unstructured":"Laukka, T. et al. Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. J. Biol. Chem. 291, 4256\u20134265 (2016).","journal-title":"J. Biol. Chem."},{"key":"230_CR137","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccell.2017.04.001","volume":"31","author":"SM Elkashef","year":"2017","unstructured":"Elkashef, S. M. et al. IDH mutation, competitive inhibition of FTO, and RNA methylation. Cancer Cell. 31, 619\u2013620 (2017).","journal-title":"Cancer Cell."},{"key":"230_CR138","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","volume":"172","author":"R Su","year":"2018","unstructured":"Su, R. et al. R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling. Cell 172, 90\u2013105 e123 (2018).","journal-title":"Cell"},{"key":"230_CR139","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1074\/jbc.M312254200","volume":"279","author":"P Koivunen","year":"2004","unstructured":"Koivunen, P., Hirsila, M., Gunzler, V., Kivirikko, K. I. & Myllyharju, J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J. Biol. Chem. 279, 9899\u20139904 (2004).","journal-title":"J. Biol. Chem."},{"key":"230_CR140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/BJ20061151","volume":"401","author":"D Ehrismann","year":"2007","unstructured":"Ehrismann, D. et al. Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem. J. 401, 227\u2013234 (2007).","journal-title":"Biochem. J."},{"key":"230_CR141","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","volume":"483","author":"P Koivunen","year":"2012","unstructured":"Koivunen, P. et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483, 484\u2013488 (2012).","journal-title":"Nature"},{"key":"230_CR142","doi-asserted-by":"crossref","first-page":"30772","DOI":"10.1074\/jbc.M304982200","volume":"278","author":"M Hirsila","year":"2003","unstructured":"Hirsila, M., Koivunen, P., Gunzler, V., Kivirikko, K. I. & Myllyharju, J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772\u201330780 (2003).","journal-title":"J. Biol. Chem."},{"key":"230_CR143","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/emboj\/16.6.1173","volume":"16","author":"J Myllyharju","year":"1997","unstructured":"Myllyharju, J. & Kivirikko, K. I. Characterization of the iron- and 2-oxoglutarate-binding sites of human prolyl 4-hydroxylase. EMBO J. 16, 1173\u20131180 (1997).","journal-title":"EMBO J."},{"key":"230_CR144","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.celrep.2015.11.029","volume":"13","author":"P Wang","year":"2015","unstructured":"Wang, P. et al. Oncometabolite D-2-hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents. Cell Rep. 13, 2353\u20132361 (2015).","journal-title":"Cell Rep."},{"key":"230_CR145","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cmet.2015.06.009","volume":"22","author":"X Fu","year":"2015","unstructured":"Fu, X. et al. 2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling. Cell. Metab. 22, 508\u2013515 (2015).","journal-title":"Cell. Metab."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0230-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-019-0230-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:10:32Z","timestamp":1684617032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0230-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["230"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0230-6","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}